David Shapiro
Founding Managing Partner @ Blue Ivy Ventures
Waltham, United States
David Shapiro is a Series B investor at Blue Ivy Ventures in Waltham focused on Software and Health Care. David has over 25 years of experience as an investor, advisor, and board member, with expertise across early and late stage venture capital, growth investing and secondary deals, as well as in technology operations and entrepreneurship. Before joining Blue Ivy, David was Senior VP Corporate Development and Business Development for DataXu, amarketer-aligned data and analytics company.
- Total investments:
- 74
- Last investment:
- Lead investor:
- 15%
Last updated:
For AI agents: llms.txt
Industries David Shapiro invests in
Stages David Shapiro invests in
Countries David Shapiro invests in
Investment Focus
Industry
- Software 16 (22%)
- Health Care 11 (15%)
- Artificial Intelligence 10 (14%)
- Information Technology 8 (11%)
- Medical 7 (9%)
Stage
- Series B 17 (23%)
- Series A 14 (19%)
- Seed 13 (18%)
- Series C 10 (14%)
- Series D 5 (7%)
Country
- United States 53 (72%)
- India 1 (1%)
- Israel 1 (1%)
- Singapore 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Performance Drone Works
|
PDW is a family of small autonomous platforms designed for the modern warfighter. It has a record of developing novel technology across a large stack in suas design. Its systems share the common design in electronics and software across three different sized platforms. | $110M / Series B / Mar 25, 2026 | |
Zeno
|
Zeno is a climate conscious motor company that offers eco-friendly motorcycles. | $20.5M / Series A / Mar 05, 2026 | |
Wasabi Technologies
|
Wasabi provides simple, predictable and affordable hot cloud storage for businesses all over the world. It enables organizations to store and instantly access an unlimited amount of data at 1/5th the price of the competition with no complex tiers or unpredictable egress fees. Trusted by tens of thousands of customers worldwide, Wasabi has beenrecognized as one of technology’s fastest-growing and most visionary companies. Created by Carbonite co-founders and cloud storage pioneers David Friend and Jeff Flowers, Wasabi has secured nearly $275 million in funding to date and is a privately held company based in Boston. | $70M / Series E / Jan 12, 2026 | |
Cambium
|
Cambium develops biomaterials for fields such as defense, space transport, aerospace, and renewable energy. Leveraging the Deep Tech convergence between synthetic biology, materials science, computation & automation, it delivers radical step changes in advanced material performance and sustainability to improve today’s products and enabletomorrow’s. | $100M / Series B / Jan 05, 2026 | |
Maritime Fusion
|
Maritime Fusion specializes in the development and construction of high-temperature superconducting (HTS) fusion reactors. | $4.5M / Seed / Nov 24, 2025 | |
Function Health
|
Function Health is a health platform offering lab tests to help individuals monitor their health. | $298M / Series B / Nov 19, 2025 | |
Ursa Major
|
Ursa Major Technologies develops innovative propulsion solutions for the emerging microsatellite and nanosatellite launch market. Its advanced manufacturing optimizes unique part creation. These engines are greater than 80% additively manufactured by mass using cutting-edge, internally-developed materials and processes.The company was founded in2015 and is based in Berthoud, Colorado. | $100M / Series E / Nov 18, 2025 | |
Formic Technologies
|
At Formic, we want to increase the collective output of humanity by making automation deployments trivial and easy. Every factory should have access to unlimited 'labor' through robotics and automation rentals. We are building technology, financing, operations and services to make this vision possible.Formic is a fast-growingventure-backed startup focused on unlocking robotic automation in labor-starved industries such as food and beverage, advanced manufacturing, consumer packaged goods and other industrial settings. We combine financial innovation with a firm understanding of what robotics are capable of, to enable manufacturing customers to scale up their manufacturing capacity quickly and with minimal risk. | $469.7K / Series B / Oct 27, 2025 | |
Rubedo Life Sciences
|
Rubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells. | Series B / Oct 23, 2025 | |
Prorata.AI
|
ProrataAI builds technology that enables generative AIs to properly attribute contributing content and share revenues on a per-use basis. | $40M / Series B / Sep 05, 2025 | |
| See all 74 investments → | |||
Co-Investors
About Blue Ivy Ventures
Blue Ivy Ventures is a community of Yale alumni: investors, executives, entrepreneurs, and innovation enthusiasts with a connection to Yale University. Blue Ivy Ventures was founded in 2016 and is led by Managing Partner David Shapiro (Yale '91). Its Investment Committee and investors include experienced investors and entrepreneurs fromaround the country and across multiple generations.
Blue Ivy Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
David Shapiro
Founding Managing Partner
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does David Shapiro invest in?
David Shapiro invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Series B and Series A stage. Most of the 74 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did David Shapiro last invest?
The most recent investment recorded for David Shapiro closed in Mar 2026. Shizune tracks 74 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
